Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.)"
Count: 32
Selected: 0
NCT IDTitle
NCT03026972A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried
NCT04538911Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients
NCT04593771Phase I Clinical Protocol of BCG-PPD in Healthy People
NCT01979900Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis
NCT02623556Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen
NCT05616754A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)
NCT05574985Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)
NCT05284812A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
NCT05205096Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac
NCT05205083Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV
NCT05198102ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization
NCT05198063ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization
NCT05128643Clinical Study on the Immune Program of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell)
NCT05109598Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus(COVID-19) Vaccine (CHO Cell)
NCT05107375Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine
NCT05091411Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)
NCT05089045Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity
NCT04961359Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2(COVID-19) Phase I Clinical Trial (3~17 Years Old)
NCT04852068A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
NCT04646590A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19
NCT04563533Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)
NCT04563273Clinical Study of BCG Vaccine for Intradermal Injection
NCT04550351Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)
NCT04466085Clinical Study of Recombinant Novel Coronavirus Vaccine
NCT04445194Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine
NCT04239313A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
NCT03027154Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for Children
NCT02795260Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy)
NCT02389322Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65
NCT02336542Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10
NCT02329730Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10
NCT01999231Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10